Despite this notice, the company’s common stock will continue to trade on The Nasdaq Global Market under the symbol "GOCO" without immediate effect on its listing or trading. GoHealth has been granted a compliance period of 180 calendar days, until September 14, 2026, to regain compliance with the market value requirement. If the company's market value of listed securities closes at $35 million or more for a minimum of 10 consecutive business days during this period, Nasdaq will confirm that the company has regained compliance.
Should GoHealth fail to meet the compliance requirements within the stipulated period, it may face delisting from Nasdaq. The company has indicated that it is evaluating options to regain compliance, although there is no assurance that it will succeed in doing so. This situation raises concerns regarding the company's financial health and operational execution, which could negatively impact investor confidence and stock performance in the near term.